I've stayed in touch with the contact I referred to, and they've published some developments I sent their way re their specific professional interest, and I know their interest remains high. The ValiMed G4 through-the-container aspect is especially interesting for their particular application (non hospital).
I listened, in person, to a leading pharmacy compounding expert speak to the ValiMed team at an ASHP event about its potential, where capability needs were discussed that now appear in the ValiMed G4 literature.
PLENTY of qualified professionals are well aware of CDEX's ValiMed G4.
There is interest and awareness, so access and collaboration with qualified third party pharmacy experts and professionals is not a concern of mine. The CDEX ValiMed G4 system will be, on its own merits, adopted and used, or not adopted and used. Getting CDEX connected with qualified pharmacy experts and professionals is not a concern of mine. Keep in mind the most extensive ValiMed test so far was an 18-Month peer reviewed study which apparently required significant time between study completion and publication. Like all of us, I watch and wait with interest, but I am not concerned about CDEX access to qualified and well respected experts.
